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ABSTRACT 
The finding that aggregates of disease-unrelated proteins can induce cell death indicates that 
proteins may act as potential toxins. Cells experiencing toxic protein aggregates often display 
modifications of the redox status and ion balance, eventually leading to apoptosis; however, in 
some cases, tissue and cultured cell types die with features of necrosis. To elucidate the 
pathways leading to such different outcomes, we studied the biochemical features of death in H-
END and NIH/3T3 cells exposed to prefibrillar aggregates of a disease-unrelated protein. The 
two types of cells died by apoptosis and necrosis, respectively. The pattern of caspase and 
proapoptotic factor activation was investigated together with the extent of mitochondria 
impairment and the energy load in either cell line. Our data depict a scenario where the events 
related to the extrinsic pathway of apoptosis are the same in the two cell lines, the difference in 
the final outcome being related to the extent of mitochondria derangement, possibly due to the 
different ability of the cells to counteract ion homeostasis impairment. 
Key words: protein aggregation ● aggregate toxicity ● amyloid fibrils ● cell apoptosis ● cell 
necrosis 
he main hallmark of a number of sporadic or familial degenerative diseases, either 
systemic or affecting the central nervous system (CNS), is the presence, in the affected 
organs and tissues, of intracellular or extracellular deposits of fibrillar appearance 
(amyloid fibrils). These deposits result from the aggregation of one out of a limited number of 
peptides or proteins, each specific of a particular disease (1) after mutations, overexpression, 
chemical modifications, or impairment of cellular components of the folding quality control (1). 
Presently, there is growing interest in improving our knowledge of the molecular and 
biochemical basis of protein misfolding and aggregation as well as of aggregate toxicity to living 
systems. Such knowledge could suggest clues for the development of therapeutic strategies to 
T 
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treat pathologies with dramatic social impact, such as Alzheimer’s disease (AD) and Parkinson’s 
disease, senile systemic amyloidosis, AA and AL amyloidosis, and type II diabetes mellitus (2–
4). 
It is currently believed that peptide and protein aggregates are the main culprit of cell impairment 
eventually leading to cell death with memory loss and cognitive impairment when aggregation 
occurs in the brain. However, the type(s) of aggregates endowed with the highest toxicity and 
giving rise to the onset of neuropathic diseases are still matter of debate. An increasing body of 
evidence supports the idea that the causative agents of neuropathic protein deposition diseases 
are oligomeric assemblies (prefibrillar aggregates) preceding the appearance of mature fibrils (5–
8). In addition, it has been shown that prefibrillar aggregates of differing polypeptide chains 
share basic structural features, and this “toxic fold” appears to be associated with the impairment 
and death of exposed cells (5). Toxic prefibrillar aggregates share also common mechanisms of 
cytotoxicity, where early modifications of the intracellular redox status and ion homeostasis 
appear to play a key role (1, 9–13), although, in some cases, such as the neurodegenerative 
diseases caused by triplet expansions, other mechanisms of toxicity have been reported (14). 
It is well known that extensive death of specific neuronal populations occurs either 
physiologically, as during embryogenesis or after trauma, and in neurodegenerative diseases 
(15); however, even in this case, the pathways eventually leading to cell death are poorly 
understood at the cellular and biochemical levels. In most cases, the final outcome is cell death 
by apoptosis, although necrotic features in dead cells have also been shown (16–19). In addition, 
recently, a new type of programmed cell death induced by oxidative stress with glutathione 
depletion, referred to as oxytosis, has been reported (20). Moreover, under pathological 
conditions, apoptosis and nonapoptotic death paradigms often appear interwined, suggesting that 
in vivo cells can use diverging execution pathways (21). 
The perspective in the research on the molecular basis of protein aggregation and aggregate 
toxicity has changed since 1998, when it was first shown that the ability to misfold and aggregate 
is not a peculiar property associated with the specific amino acid sequences of the proteins and 
peptides implicated in protein deposition diseases (1); rather, it appears as an inherent property 
of the polypeptide backbone of any peptide sequence (including amino acid homopolymers) 
(22). Later on, it has been shown that even aggregates of proteins and peptides not associated 
with any amyloid disease display toxic effects on cultured cells (6, 23–25) and whole animals (S. 
Baglioni and M. Stefani, unpublished observations). 
This body of data led us to consider protein aggregation and aggregate toxicity as generic 
properties of polypeptide chains not associated with specific amino acid sequences. Hence, 
amyloid diseases are now considered pathological states arising when a natural polypeptide chain 
becomes organized so as to assemble into a generic polymer structure rather than folding in the 
biologically active three-dimensional conformation encoded into its amino acid sequence (22). 
These data led us to suggest that a higher number of degenerative diseases than presently known 
might follow the deposition of proteins and peptides presently considered not associated to 
disease (1) and that aggregation of specific proteins may be endowed with physiological 
significance in biological systems (26). 
We have previously reported that prefibrillar aggregates, but not mature fibrils, of a protein 
unrelated with any disease, the N-terminal domain of the hydrogenase maturation factor HypF 
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(HypF-N), are able to enter into NIH/3T3 cells after incubation in the culture medium. As a 
consequence, the cells display impaired viability with early modifications of basic biochemical 
parameters such as intracellular redox status and free Ca2+ (23). In this study, we have 
investigated the biochemical features of cell death upon exposure to HypF-N toxic prefibrillar 
aggregates using H-END and NIH/3T3 previously shown to display a different final outcome, 
apoptosis or necrosis, respectively, upon exposure to toxic amyloid aggregates. In addition, H-
END cells are highly sensitive to the toxic effects of the cross-β structure characteristic of 
aggregates of proteins and peptides such as Aβ peptides and are damaged in cerebral vessels of 
AD people (reviewed in ref 27). 
A better knowledge of the biochemical responses of cells exposed to toxic protein aggregates is 
of the outmost importance to know what exactly happens in tissues and organs experiencing 
protein toxic assemblies. It is also mandatory to rationally design molecules and treatments 
aimed at counteracting the harmful effects of protein aggregates on living systems and at 
favoring the natural defenses of cells and tissues against them. 
MATERIALS AND METHODS 
Materials 
HypF-N was purified as described previously (28). Ac-LEHD-AMC and cell-permeable Ac-
IETD-CHO were from Biosource International; all other caspase substrates and inhibitors were 
from Biomol Research Laboratories Inc. The Klenow-Frag-ELTM DNA fragmentation detection 
kit and the annexin V detection kit were from Oncogene Research Products (San Diego, CA). 
The lipophilic cationic probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazol-carbocyanine 
iodide (JC-1) was from Molecular Probes (Eugene, OR). The ATP assay kit was from Sigma-
Aldrich Fine Chemicals Co. (St. Louis, MO). Rabbit anti-Bax polyclonal antibody was from 
Chemicon International (Temecula, CA); rabbit anti-Bid polyclonal antibody was from Santa 
Cruz Biotechnology, Inc. (Santa Cruz, CA); and mouse anti-p53 (1C12) monoclonal antibody 
and rabbit anti-caspase-6 polyclonal antibody were from Cell Signaling Technology (Beverly, 
MA). Enhanced chemiluminescence detection substrate (ECL) was from Amersham Biosciences 
(Uppsala, Sweden). Cell culture media, materials for microscopy analysis, and other reagents 
were from Sigma-Aldrich Fine Chemicals Co. NIH/3T3 murine fibroblasts and H-END murine 
endothelioma cells (from the laboratory of F. Bussolino, University of Turin, Italy) were 
routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 g/l glucose, 
containing 10% bovine calf serum (HyClone Lab, Perbio Company, Celbio) or fetal calf serum 
(Sigma), respectively, unless otherwise stated, and 3.0 mM glutamine in a 5.0% CO2 humidified 
environment at 37°C, and 100.0 U/ml penicillin and 100.0 µg/ml streptomycin were added to the 
media. Cells were used for a maximum of 20 passages. 
Formation of prefibrillar aggregates of HypF-N 
HypF-N prefibrillar aggregates were obtained by incubating the protein for 48 h at room 
temperature at a concentration of 0.3 mg/ml in 30% (v/v) trifluoroethanol, 50 mM sodium 
acetate, 2.0 mM dithiotreitol (DTT), pH 5.5, as previously reported (28). The solution was 
centrifuged, and the resulting pellet was dried under N2 to remove the residual solvent, dissolved 
in phosphate-buffered saline (PBS), and immediately added to the cell culture medium. 
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Hematoxylin and eosin staining 
Cells were plated on glass coverslips and exposed to different final concentrations of HypF-N 
prefibrillar aggregates added to culture medium. After 24 h, cells were washed twice with PBS, 
fixed with 2.0% buffered paraformaldheyde for 10 min at room temperature, washed with PBS 
and with redistilled water, and stained for 5 min in hematoxylin. After additional washings for 5 
min with tap water and for 2 min with redistilled water, the coverslips were stained for 2 min in 
0.2% eosin; rapidly dipped in 80% ethanol (1 min), 90% ethanol (1 min), and 100% ethanol (1 
min) and xylol (5 min); mounted on slides with Canada balsam; and analyzed by light 
microscopy. 
In situ end labeling of nicked DNA 
Apoptotic cells were identified by light microscopy after end labeling of DNA fragments by 
using the Klenow-Frag-EL DNA fragmentation detection kit (ISEL assay) according to the 
instructions provided by the manufacturer. Briefly, cells were exposed to various concentrations 
of HypF-N prefibrillar aggregates or to the same amounts of monomeric HypF-N. After 24 h, 
exposed cells were fixed in 2.0% buffered paraformaldheyde (10 min) and incubated with 20 
µg/ml proteinase-K for 5 min at room temperature to remove the excess proteins from the nuclei. 
Endogenous peroxidase was inactivated by covering the cells with 3.0% H2O2 for 5 min at room 
temperature. Then the cells were incubated with the Klenow fragment of DNA polymerase-I and 
biotinylated deoxyribonucleotides in a humidified chamber at 37°C for 1.5 h. The reaction was 
stopped by moving the slides with the adherent cells into the blocking solution (300 mM NaCl, 
30 mM sodium citrate) for 15 min at room temperature. After incubation for 10 min with 
streptavidin-peroxidase, the cells were stained with diaminobenzidine for 10 min at room 
temperature. Diaminobenzidine reacts with the labeled fragmented DNA of apoptotic cell nuclei, 
generating a dark brown insoluble chromogen. Counterstaining was performed with methyl 
green. The number of the cells displaying nuclear staining was determined by counting four 
different fields each containing ~50 cells. 
Annexin V and propidium iodide labeling 
Cells undergoing early apoptosis were evidenced by phosphatidylserine (PS) staining using an 
annexin V detection kit according to the instructions of the manufacturer. Briefly, control cells 
exposed to 2.0 µM monomeric HypF-N and cells exposed to 2.0 µM HypF-N prefibrillar 
aggregates were gently detached with 0.25% trypsin in PBS, centrifuged at 1800 rpm for 10 min, 
and resuspended in DMEM at 106 cells/ml. The cells were double-stained with FITC-conjugated 
annexin V, which binds to PS, while nuclei were stained with propidium iodide. The specimens 
were analyzed with a Bio-Rad 1024 ES confocal laser scanning microscope (Bio-Rad, 
Hampstead, UK) with laser beam excitation at 488 and 568 nm wavelengths. 
Caspase activity assay 
Cells exposed to the HypF-N prefibrillar aggregates were washed twice with PBS and then lysed 
for 20 min at 0-4°C in 20 mM Tris-HCl buffer, pH 7.4, containing 250 mM NaCl, 2.0 mM 
EDTA, 0.1% Triton X-100, 5.0 µg/ml aprotinin, 5.0 µg/ml leupeptin, 0.5 mM 
phenylmethylsulfonylfluoride, 4.0 mM sodium vanadate, and 1.0 mM DTT. The lysis was 
completed by sonication, and total protein content was determined in the clarified lysates with 
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the Bradford reagent. Aliquots of total proteins (50 µg for caspase-9 assay, 250 µg for caspase-8 
and caspase-3 assays) were diluted in 50 mM HEPES-KOH buffer, pH 7.0, containing 10% 
glycerol, 0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate, 2.0 mM EDTA, 
10 mM DTT. Caspase-9 activity was determined by incubating a protein sample for 2 h at 37°C 
in the presence of 50 µΜ Ac-LEHD-AMC (fluorometric substrate; excitation 380 nm, emission 
460 nm). Caspase-3 and -8 activities were determined by incubating a protein sample for 4 h at 
37°C in the presence of 200 µΜ Ac-DEVD-pNA and 200 µΜ Ac-IETD-pNA, respectively, and 
evaluating sample extinction at 405 nm. To determine nonspecific substrate degradation, the 
assays were also performed by preincubating total protein samples for 15 min at 37°C with or 
without the specific caspase inhibitor (100 nM Ac-DEVD-CHO for caspase-3; 50 µΜ Ac-IETD-
CHO for caspase-8; 10 µΜ Ac-LEHD-CHO for caspase-9) before substrate addition. As a 
positive control, cells were treated with 2.0 µM staurosporine for 5 h before lysis. In some 
experiments, cells were pretreated for 2 h with a cell permeable caspase-8 inhibitor (10 µM) 
before exposure to the prefibrillar aggregates. 
Determination of mitochondrial membrane potential in living cells 
The change of the mitochondrial membrane potential (∆ΨM) occurring during apoptosis was 
detected by a fluorescence-based assay. NIH/3T3 and H-END cells were incubated for 10 min at 
37°C on coverslips in DMEM containing 5.0 mg/ml of the lipophilic cationic probe JC-1. At 
hyperpolarized membrane potentials (-140 mV), the dye forms a red fluorescent J-aggregate, 
whereas at depolarized membrane potentials (-100 mV), it remains in the green fluorescent 
monomeric form. Before detection, cells were washed in PBS and placed in an open slide-flow 
loading chamber that was mounted on the stage of a Bio-Rad MRC 1024 ES Confocal Laser 
Scanning Microscope (CLSM) equipped with a Krypton/Argon (Kr/Ar) laser source. The emitted 
fluorescence was monitored at 488 and 568 nm with a Nikon plan ApoX60 oil-immersion 
objective. Series of optical sections (512×512 pixels) were taken trough the depth of cells with a 
thickness of 1.0 µm at intervals of 0.8 µm. Twenty optical sections for each sample were 
projected as a single composite image by superimposition. 
Intracellular ATP assay 
Intracellular ATP was measured by a somatic cell assay kit based on luciferin-luciferase reaction 
according to the instructions provided by the manufacturer. When ATP is the limiting component 
in the luciferase reaction, the intensity of the emitted light is proportional to the ATP 
concentration in the cytosolic extract. Briefly, nonconfluent cells were incubated with 2.0 µM 
HypF-N prefibrillar aggregates or with the same concentration of monomeric HypF-N as a 
control in fresh medium. After 24 h, the cells were washed twice with PBS, trypsinized and 
resuspended in fresh DMEM without phenol red, and supplemented with 10% bovine calf serum. 
Cells were counted and diluted to a final density of 2 × 105 cells/ml. The ATP content was 
measured in light intensity using a Berthold Lumat LB 96507 luminometer, and the percent 
variation was calculated for every cell line with respect to its control. 
Western blot analysis 
After treatment with 2.0 µM HypF-N prefibrillar aggregates or with 2.0 µM soluble HypF-N as a 
control, cells were washed twice with PBS and lysed in RIPA buffer [50 mM Tris-HCl buffer, 
Page 5 of 23
(page number not for citation purposes)
pH 8.0, 150 mM NaCl, 1.0% (v/v) Nonidet P-40, 0.1% (w/v) SDS, 0.5% (w/v) sodium 
deoxycholate, 1.0 mM sodium vanadate, 10 µg/ml leupeptin, 20 µg/ml aprotinin, and 1.0 mM 
PMSF] for 30 min in ice. Protein concentration was determined by the bicinchoninic acid assay. 
Equal protein amounts were run in SDS-PAGE and transferred to PVDF membranes. Blots were 
incubated with primary antibodies (anti-Bid 1:500, anti-p53 1:1000, anti-Bax 1:1500, anti-
caspase-6 1:500) at 4°C overnight. After being washed, the blots were stained with peroxidase-
conjugated secondary antibody and the bands were visualized by ECL. Images were acquired 
with ChemiDoc apparatus (Bio-Rad), and densitometric analysis of bands was performed using 
QuantiScan software (Bio-Rad). 
RESULTS 
HypF-N prefibrillar aggregates induce apoptosis in H-END and necrosis in NIH/3T3 cells 
NIH/3T3 and H-END cells were treated for various intervals of time with different 
concentrations of toxic HypF-N prefibrillar aggregates to test aggregate cytotoxicity and to 
determine the mode of cell death. Controls were performed by exposing the cells to the same 
amount of soluble HypF-N (Fig. 1A and D). NIH/3T3 cells exposed for 24 h to 10 µM 
(monomeric protein concentration) HypF-N prefibrillar aggregates died with necrotic features, 
such as cellular and nuclear swelling and cytoplasmic vacuolization, as shown by hematoxylin 
and eosin staining (Fig. 1E and F). In contrast, under the same conditions, H-END cells 
displayed typical features of apoptosis, such as nuclear condensation, chromatin aggregation, and 
plasma membrane blebbing (Fig. 1B and C). Apoptotic cells were also recognized on the basis of 
their characteristic DNA fragmentation by nick-end labeling with the Klenow-FragEl method. 
This treatment allows easy recognition apoptotic cells by the presence of a dark brown nuclear 
staining, whereas viable cells appear green or even unstained. Exposed H-END cells displayed 
oligo-nucleosomal DNA fragmentation (Fig. 2B). No DNA fragmentation was observed in 
NIH/3T3 cells under the same conditions, although sample counterstaining revealed the presence 
of cytoplasmic vacuolization (Fig. 2D). No DNA fragmentation was observed in control cells of 
both lines (Fig. 2A and C). 
Figure 2, lower panel, shows the number of apoptotic H-END cells after 24 h exposure as a 
function of the amount of prefibrillar aggregates added to the culture medium. The percentage of 
apoptotic nuclei increases with the concentration of prefibrillar HypF-N aggregates, reaching 
18% at the highest tested concentration (10 µM). At 24 h of exposure and 2.0 µM concentration 
of HypF-N aggregates, ~8.0% of the cells showed brown stained nuclei (1.0% in control cells); 
this concentration was chosen to investigate finely regulated biochemical processes, such as the 
activation of proapoptotic factors, that could have been obscured by a stronger cell injury. 
A key apoptotic event is the modification of the plasma membrane composition, a signal for 
recognition and engulfment by phagocytes before membrane integrity is compromised (29). A 
marker for phagocytosis is the exposure of PS, a phospholipid normally found in the inner leaflet 
of the cell membrane that flips to the outer leaflet during the early stages of apoptosis (29). 
Annexin V preferentially binds to PS and can be used to detect PS exposure on the external 
surface of apoptotic cells (30). 
H-END and NIH/3T3 cells were exposed for 24 h to 2.0 µM prefibrillar aggregates or to 2.0 µM 
soluble protein as a control. While control cells displayed no annexin V-FITC binding and an 
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unaffected plasma membrane (Fig. 3A), exposed H-END cells displayed annexin V positivity as 
an annular staining of the cell membrane, indicating membrane integrity but PS exposure on the 
membrane external surface (Fig. 3B). In contrast, in NIH/3T3 cells exposed to the HypF-N 
aggregates a cytoplasmic staining was observed, suggesting the presence of plasma membrane 
ruptures as a consequence of necrosis (Fig. 3D). To explain the different effects caused by the 
exposure to the HypF-N prefibrillar aggregates in H-END and NIH/3T3 cells, the biochemical 
pathways involved in aggregate toxicity were investigated in more detail. 
Caspase activation during H-END and NIH/3T3 cell death 
Caspase activity was determined in NIH/3T3 and H-END cells exposed for 5, 8, 16, and 24 h to 
2.0 µM HypF-N prefibrillar aggregates or to the soluble protein. In H-END cells exposed for 5, 
16, and 24 h to the aggregates, caspase-8 activity was 280, 150, and 350% of that observed in 
control cells, respectively. No significant increase of caspase-8 activity was found in cells 
exposed for 8 h (Fig. 4, upper panel). At 5, 8, and 24 h of exposure, a higher (~150%) caspase-3 
activity was also detected in cells, whereas no differences with respect to controls were found 
after 16 h exposure (Fig. 4, upper panel). A modest caspase-9 activation was observed only at 
prolonged times of exposure (16 and 24 h) and was followed by a late (24 h) caspase-3 activity 
increase (Fig. 4, upper panel). The rise of caspase-3 activity in cells exposed 24 h to the 
aggregates could be the effect of the activation of either the extrinsic and/or the intrinsic 
pathway; in addition, the previously reported activity of caspase-3 on procaspase-8 (31, 32) 
might explain the strong caspase-8 activation in these cells at 24 h. 
In exposed NIH/3T3 cells, the pattern of caspase activation was quite different. An eightfold 
early increase of the caspase-9 activity was observed together with a much lower caspase-8 and 
caspase-3 activation at 5 h of exposure. At prolonged times of exposure, all three caspase 
activities declined toward control levels (Fig. 4, lower panel). 
Role of Bid and mitochondria involvement 
It is known that caspase-8-mediated cleavage of Bid may be a link between the extrinsic and the 
intrinsic pathways of apoptosis (15). Therefore, we investigated whether a proteolysis of Bid 
occurred in cells exposed to the HypF-N aggregates. Figure 5 shows a significant decrease of Bid 
both in H-END and NIH/3T3 cells exposed 5 and 8 h to the aggregates, whereas it rises again at 
higher times of exposure; this finding agrees with the similar extent of caspase-8 activation 
observed at 5 h in the two cell lines (Fig. 4). These data support the idea that the difference of the 
behavior of the two cell lines could rely, at least in part, on the early caspase-9 activation found 
in NIH/3T3 cells exposed to the aggregates. Therefore, we investigated the possible involvement 
of mitochondria in the aggregate-induced biochemical damage by checking the mitochondrial 
membrane potential in both cell lines. 
Membrane depolarization was monitored by the uptake of 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazol-carbocyanine iodide (JC-1) leading to a shift in mitochondrial 
fluorescence from red to green. Exposed NIH/3T3 cells displayed a significant early 
mitochondrial membrane depolarization after 3 h exposure to the prefibrillar aggregates (Fig. 6E) 
that was maintained at longer times of exposure (Fig. 6F). This finding agrees with the early 
caspase-9 activation observed in this cell line. Most of the H-END cells displayed mitochondrial 
membrane depolarization only after 24 h exposure (Fig. 6C), whereas no significant 
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depolarization was observed at 3 h exposure to the aggregates (Fig. 6B), in agreement with the 
late caspase-9 activation found in this cell line. These data, together with the observed caspase-8-
dependent proteolysis of Bid, suggest that mitochondrial injury is not the primary event of the 
apoptotic process in H-END cells but could be a late consequence of the activation of the 
extrinsic pathway. 
Actually, when H-END cells were treated with a cell permeable caspase-8 specific inhibitor 
before the exposure to the HypF-N aggregates for 24 h, caspase-8 and caspase-9 activities were 
reduced by 36 and 28%, respectively (data not shown). Such caspase-9 activity reduction 
correlates with the disappearance of Bid cleavage during cell treatment with caspase-8 inhibitor 
(Fig. 7A). The decrease in caspase-8 activity on Bid makes it possible to observe an increase of 
Bid over control levels after cells treatment with HypF-N prefibrillar aggregates (Fig. 7A) that 
could be due to the up-regulation of the expression of the corresponding gene after p53 
activation (33). Hence, we ascertained whether the p53 content was increased in exposed H-END 
cells. 
The p53 pathway contributes to the apoptotic program in cells exposed to the aggregates 
The possible involvement of p53 in H-END apoptosis was investigated by determining the p53 
levels in cells exposed to the HypF-N aggregates together with the expression levels of two p53 
targets, Bax and caspase-6. Western blot analysis reveals that all three proteins increased in the 
exposed cells with respect to controls, with apparent maxima at 5 h for p53 and caspase-6 and at 
8 h for Bax (Fig. 7B). A similar behavior was displayed by Bid when caspase-8 was inhibited 
before cell exposure to the aggregates (Fig. 7A). This expression pattern suggests a contribution 
of the p53 pathway to H-END apoptosis triggered by the exposure to the HypF-N prefibrillar 
aggregates. 
Intracellular ATP levels 
To further support the idea that mitochondrial injury could explain the necrotic pattern observed 
in NIH/3T3, intracellular ATP levels were measured in both cell lines exposed 24 h to 2.0 µM 
aggregated or monomeric HypF-N. A 30% decrease in the ATP level with respect to controls 
was observed in NIH/3T3, whereas under the same conditions ATP levels in H-END cells were 
the same as in control cells (data not shown). The reduction of the ATP levels in NIH/3T3 cells 
could explain the finding that although these cells trigger the apoptotic program, as shown by the 
early activation of caspase-9 and 3, they are not able to complete it. This is indeed in agreement 
with previous reports indicating that the apoptotic program requires energy to proceed (34, 35). 
DISCUSSION 
We have previously reported that NIH/3T3 cells exposed to prefibrillar aggregates of HypF-N 
display impaired viability (6) and eventually die after early biochemical changes of intracellular 
free Ca2+ concentration and redox status (23). In this study, we have investigated in depth the 
biochemical features of cell death in two cell lines that undergo apoptosis (H-END) or necrosis 
(NIH/3T3) upon exposure to the HypF-N aggregates. 
It is generally believed that cell death associated with protein aggregates is a result of the 
stimulation of the apoptotic response (14, 16, 36, 37). This seems to be the case for misfolded 
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variants of proteins, such as α-lactalbumin or Aβ1-42, that are able to trigger apoptosis 
specifically in tumor (38) or neuronal (36) cells, respectively. Other recent data, however, 
suggest that Aβ1-40 stimulates cell death both in culture (PC12) and in vivo (brain) via a necrotic 
rather than an apoptotic pathway (17–19, 39). Alternatively, when both processes occur, either a 
relatively small population of dying cells undergo apoptosis (17, 18) or cells die by secondary 
necrosis, a sequential event in the development of apoptosis in vitro (15, 16). 
Recent data point to derangement of ion homeostasis and oxidative stress as key event 
underlying cell death in cells exposed to toxic protein aggregates (10, 11, 40–45). These data are 
reinforced by recent findings indicating that caspase-3 can cleave the plasma membrane Ca2+-
ATPase (46), the loss of function of which during apoptosis results in Ca2+ overload and 
secondary cell lysis or necrosis (15). Our results agree with these data, since, after an initial 
increase of caspases activity, necrosis appears to be the dominant feature of death in NIH/3T3 
cells. 
The pattern of caspase activation in the two investigated cell lines exposed to the aggregates is 
consistent with their different fate. In H-END cells, a remarkable activation of caspase-8 and a 
less pronounced activation of caspase-3 were found. In both cases, the activation was biphasic, 
displaying minima in cells exposed 8 (caspase-8) or 16 (caspase-3) h; caspase-9 activation 
occurred later and was only found in cells exposed 16 and 24 h. As caspase-3 is an effector 
caspase, downstream to caspase-8 and caspase-9, this pattern is consistent with an initial 
activation of caspase-3 by caspase-8 followed by a reactivation by caspase-8 and caspase-9 at 
later times of exposure. Since caspase-3 can activate caspase-8 (31, 32), the second wave of 
caspase-8 activity could represent a positive feedback arising from the initial caspase-3 
activation. Our findings agree with recent data showing that Chinese hamster V79 cells and 
human K562 cells exposed 20 h to aggregates of an 11-Ala peptide display increased caspase-8 
and caspase-3 activities before the apoptotic outcome (47). 
Apparently, under these conditions, the extrinsic and the intrinsic pathways of apoptosis are 
activated in H-END cells, in agreement with previous findings showing that the aggregates are 
able to interact with the plasma membrane and to translocate into the cytosol (23) where they can 
interact with other organelles. Previously, it was reported that a molecular link, relying on the 
production of a truncated form of Bid, does exist between the extrinsic and the intrinsic pathway 
of apoptosis (48–50). The product of Bid cleavage by caspase-8 (tBid) translocates to the 
mitochondria where it induces oligomerization and insertion of Bax and/or Bak into the outer 
membrane; the subsequent membrane permeabilization (51) releases to the cytosol death-
promoting factors such as cytochrome c, with apoptosome formation and caspase-9 activation 
(52). 
Actually, in H-END cells exposed to the aggregates, we found a significant decrease of Bid and 
hence, presumably, an increase of its cleaved form. Such a decrease reached the maximum at 8 h 
exposure, possibly after the preceding caspase-8 activation; in the presence of the cell-permeable 
caspase-8 inhibitor, the decrease of Bid was not found. Taken together, our results support the 
hypothesis of a cross-talk between the extrinsic and intrinsic pathway in exposed H-END cells. 
In fact, the appearance of caspase-9 activity at later times of exposure to preaggregates in H-
END cells suggests it follows caspase-8 activation via Bid cleavage. Coherently, the reduction in 
caspase-8 activation coming from pretreatment with the caspase-8 inhibitor results in a 
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diminished caspase-9 activity. 
In this contest, the Bax increase in cells exposed 8 h to HypF-N preaggregates would favor the 
subsequent caspase-9 activation, interacting with tBid to promote the mitochondrial membrane 
permeabilization. The increase of Bax in exposed H-END cells suggests that p53 may contribute 
to the overall apoptotic pathway. Recent papers have reported that p53 and Bax are activated in 
cells microinjected with Aβ1-42 (36) and that p53 is activated in cells affected by differing 
cellular stresses, supporting its role as apoptosis trigger by transcriptional induction of a wide 
network of target genes (53, 33). In addition to Bax, Bid is also transcriptionally regulated by p53 
in response to stress stimuli such as γ-irradiation (33). 
The levels of either p53 or of two p53-upregulated gene products, Bax and caspase-6, further 
support the involvement of the p53 pathway in the apoptosis of exposed H-END cells. In fact, 
the content of p53 increased sharply in cells exposed 5 h to the aggregates but progressively 
declined at longer times of exposure. Accordingly, the content of Bax, and, to a lesser extent, of 
caspase-6, increased at 5-8 h of exposure; moreover, an increase of Bid was observed when 
caspase-8 was inhibited. An increase of caspase-6 activity in human neurons committed to 
apoptosis in AD brains has previously been reported, supporting the idea that caspase-6 is 
involved in apoptosis of primary cultures of human neurons (54). Altogether, our data suggest 
the participation of p53 to the apoptotic program triggered in H-END cells exposed to the 
aggregates. 
Our data may also contribute to explaining why NIH/3T3 cells are not able to support the 
initially triggered apoptotic program and eventually die by necrosis (or by secondary necrosis). 
Figure 4 shows that, in these cells, caspase-9 undergoes strong early, though not sustained, 
activation. The comparison of the patterns of caspase activation in NIH/3T3 and H-END cells 
shows that, while both undergo similar caspase-8 and caspase-3 activation and similar 
proteolysis of Bid at 5 h and 8 h exposure, the early and strong caspase-9 activation is found only 
in NIH/3T3. Such a strong activation agrees with the significant mitochondrial membrane 
depolarization in these cells exposed 3 h to the aggregates; instead, at the same time of exposure, 
no significant mitochondrial membrane depolarization was observed in H-END cells, where 
mitochondrial damage was found only at 24 h exposure, in agreement with the late caspase-9 
activation. 
These data suggest that the mitochondrial injury is not the primary event of the apoptotic process 
in H-END cells, but it can follow the activation of the extrinsic pathway possibly elicited by 
preaggregate interaction with the plasma membrane. Other triggers of the extrinsic pathway 
cannot be ruled out: in various cell lines an induction by p53 of the CD95 death receptor 
expression has been shown (55, 56). Moreover, a ligand-independent activation of Fas by 
ultraviolet radiation, cytotoxic drugs, or ROS was reported (57–59). Finally, the disruption of 
lipid rafts leads to a spontaneous clustering of Fas in the nonraft compartment of plasma 
membrane, with subsequent activation of caspase-8 and apoptosis (60). 
NIH/3T3 cells seem to experience a primary activation of the intrinsic pathway, as indicated by 
the early onset of caspase-9 activity. The differing mitochondria involvement in cell death in 
either cell line is confirmed by the measurements of the ATP content in NIH/3T3 and H-END 
cells exposed 24 h to the aggregates. A sharp reduction of the energy load was found only in 
NIH/3T3 cells, confirming the heavier mitochondrial damage in these cells and providing a 
Page 10 of 23
(page number not for citation purposes)
possible clue to explain their inability to support the initially triggered apoptotic program. In fact, 
it is known that apoptosis requires high energy levels and that the same are dissipated during 
necrosis (34, 35). Evidence that cells targeted to apoptosis are forced to die by necrosis when 
intracellular ATP is depleted has previously been reported (35). A stronger and earlier 
mitochondrial injury could explain ATP depletion and the consequent necrotic degeneration 
observed in NIH/3T3 cells. A possibility is that the early increase of free Ca2+ and ROS 
previously reported in exposed NIH/3T3 cells (23) may be responsible of the early mitochondria 
involvement. It is known that free Ca2+ can interact with cardiolipin, to which cytochrome c is 
anchored; such a binding and/or cardiolipin oxidation favor cytochrome c release with the 
subsequent caspase-9 and caspase-3 activation (15). A large body of data supports the idea that 
the point of no return in cell necrosis depends on the loss of function of mitochondria (61) after 
the opening of the permeability transition pore triggered by the accumulation of Ca2+, with 
subsequent outer membrane depolarization (61). Our data agree with these findings in that, at 
short times of exposure to the aggregates of the NIH/3T3, mitochondria appear to be heavily 
affected, as shown by the mitochondrial membrane depolarization and the early massive increase 
of caspase-9 that is released from mitochondria during the Ca2+-mediated permeability transition. 
Our data, together with those previously reported (23), support the existence, at least in most 
cases, of a common mechanism of aggregate toxicity to cells regardless of the origin and amino 
acid sequence of the aggregated polypeptide. This seems to proceed through free Ca2+ and ROS 
increases and activation of the apoptotic extrinsic pathway followed, when possible, by the 
intrinsic pathway. Our data also indicate that the different choices between apoptosis and 
necrosis could depend on the timing and severity of mitochondria derangement. 
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Figure 1. Light microscopic examination of haematoxylin/eosin stained H-END and NIH/3T3 cells 24 h exposed to 
the toxic HypF-N prefibrillar aggregates (10 µM). Cells grown on glass cover slips were 24h exposed to 10 µM soluble 
HypF-N or 10µM prefibrillar aggregates of HypF-N added to culture medium. Cell morphology was observed by 
haematoxylin/eosin staining and light microscopy examination. A and D) Control cells exposed for 24 h to 10 µM soluble 
HypF-N. B, C, E, and F) Cells exposed for 24 h to 10 µM prefibrillar aggregates of HypF-N. 
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Figure 2. Apoptosis determination with Klenow FragELTM DNA fragmentation detection Kit (ISEL assay). Photos: 
DNA fragmentation was detected by in situ end labeling (ISEL) technique of nicked DNA. Counterstaining was performed 
with methyl green. Cells were 24 h exposed to 10 µM soluble HypF-N (controls) or 10 µM prefibrillar aggregates added to 
culture medium. A and C) control cells; B and D) treated cells. Graph: Dose-dependent effect of prefibrillar HypF-N 
aggregates on percentage of apoptotic H-END cells after 24 h treatment. Control is treatment with 10 µM soluble HypF-N. 
Count of apoptotic nuclei was performed by light microscopy observation of cells stained with Klenow FragEL Kit. Four 
representative fields containing ~50 cells were analyzed. Data are means ± SD of 2 distinct experiments. 
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Figure 3. Annexin V-FITC binding to H-END and NIH/3T3 cells after 24 h exposure to the HypF-N prefibrillar 
aggregates (2 µM). Cellular nuclei were stained in red with propidium iodide (PI). Fluorescein isothiocyanate (FITC)-
conjugated annexin V binds to phosphatidylserine exposed to the outer surface of the plasma membrane during early stages 
of apoptosis. A and C) Control H-END (A) or NIH/3T3 (C) cells exposed for 24 h to 2.0 µM soluble HypF-N. B and D) H-
END (B) or NIH/3T3 (D) cells exposed for 24 h to 2.0 µM prefibrillar HypF-N. 
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Figure 4. Time course of caspase activity in H-END and NIH/3T3 cells after incubation with 2.0 µM toxic HypF-N 
prefibrillar aggregates. Caspase-9 activity was determined incubating cellular lysates for 2 h at 37°C in the presence of 
50 µΜ Ac-LEHD-AMC. Caspase-3 and -8 activities were determined incubating for 4h at 37°C in the presence of 200 µΜ 
Ac-DEVD-pNA and 200 µΜ Ac-IETD-pNA respectively. Values are means ± SD of 3 replicates and are expressed as 
percent respect to values found in control cells (100%) treated with 2 µM soluble HypF-N for corresponding intervals of 
time. These data come from 1 experiment out of 10, which gave qualitatively identical results. 
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Fig. 5 
 
        
Figure 5. Analysis of Bid levels. Cells were treated for short time intervals (5 h, 8 h) or long time intervals (16 h, 24 h) 
with 2 µM HypF-N prefibrillar aggregates. Controls (CI for short and CII for long time intervals) were treated with 2.0 µM 
soluble protein. Cell lysates were obtained and equal protein amounts subjected to 15% SDS-PAGE and Western blotting 
with anti-Bid antibodies. Densitometric analysis of bands was performed using QuantiScan software. Histograms are 
intensity of bands when controls were made 100%. This is a representative experiment out of 5 that gave qualitatively 
identical results. 
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Fig. 6 
 
                  
Figure 6. JC-1 analysis of mitochondrial membrane potential ∆ΨM in H-END and NIH/3T3 cells. Change in ∆ΨM 
was detected by a fluorescence-based assay. For experimental details, see Materials and Methods. Left panels: H-END 
cells. Right panels: NIH/3T3 cells. A and D) Control cells exposed 24 h to 2.0 µM soluble HypF-N. B and E) Cells 
exposed for 3 h to 2.0 µM HypF-N prefibrillar aggregates. C and F) Cells exposed for 24 h to 2.0 µM prefibrillar 
aggregates of HypF-N. 
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Fig. 7 
 
                                
 
Figure 7. Analysis of p53 activation during H-END cells treatment with HypF-N prefibrillar aggregates.  A) 
Analysis of Bid levels following caspase-8 inhibition. Cells were pretreated for 2 h with 10 µM cell permeable Ac-IETD-
CHO prior to 2.0 µM HypF-N pre-fibrillar aggregates addition. Cells that did not receive the caspase-8 inhibitor received 
an equal amount of DMSO (vehicle). Cell lysates were obtained and equal protein amounts subjected to 15% SDS-PAGE 
and Western blotting with anti-Bid antibodies. This is a representative experiment out of three that gave qualitatively 
identical results. C: controls; H: treated with HypF-N prefibrillar aggregates; H+I: treated with caspase-8 inhibitor before 
HypF-N addition. B) Analysis of p53, Bax and caspase-6 level during H-END cells treatment with HypF-N prefibrillar 
aggregates. Cells were treated for short time intervals (5 h, 8 h) or long time intervals (16 h, 24 h) with 2 µM HypF-N 
prefibrillar aggregates. Controls (CI for short and CII for long time intervals) were treated with 2.0 µM soluble protein. Cell 
lysates were obtained and equal protein amounts subjected to 15% SDS-PAGE and Western blotting with anti-p53, anti-
Bax or anti-caspase-6 antibodies. This is a representative experiment out of 5 that gave qualitatively identical results. 
Densitometric analysis of bands was performed using QuantiScan software. Histograms are intensity of bands considering 
controls as 100%. 
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